Jan 30 (Reuters) - India's Dr Lal Path Labs (DLPA.NS), opens new tab reported a 19% jump in its third-quarter profit on Thursday, led by continued demand for its bundle test offerings, sending its ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

(Reuters) – India’s Dr Lal Path Labs reported a 19% jump in its third-quarter profit on Thursday, led by continued demand for its bundle test offerings, sending its shares 3% higher. The company’s ...

JAMMU, Jan 31: The 670th Jayanti of Bawa Lal Ji Maharaj, a spiritual saint of India, was celebrated with religious fervor and gaiety at his temple at Jain Bazaar, here today. In this connection, a ...

New Delhi: India's Dr Lal Path Labs reported a 19per cent jump in its third-quarter profit on Thursday, led by continued demand for its bundle test offerings, sending its shares 3per cent higher.

Strengthening the Khas-Arya supremacy appears to be the main agenda of the Oli government.

Diagnostics chain Dr Lal PathLabs, plans to open 15-20 new labs this financial year 2024-25 (FY25). In an interview with CNBC-TV18, CEO Shankha Banerjee discussed the company’s target to maintain ...

Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.